Susan Horvath - Net Worth and Insider Trading

Susan Horvath Net Worth

The estimated net worth of Susan Horvath is at least $358 dollars as of 2024-06-10. Susan Horvath is the V.P. of Finance & CFO of Panbela Therapeutics Inc and owns about 894 shares of Panbela Therapeutics Inc (PBLA) stock worth over $358. Details can be seen in Susan Horvath's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Susan Horvath has not made any transactions after 2023-01-30 and currently still holds the listed stock(s).

Transaction Summary of Susan Horvath

To

Susan Horvath Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Susan Horvath owns 1 companies in total, including Panbela Therapeutics Inc (PBLA) .

Click here to see the complete history of Susan Horvath’s form 4 insider trades.

Insider Ownership Summary of Susan Horvath

Ticker Comapny Transaction Date Type of Owner
PBLA Panbela Therapeutics Inc 2023-01-30 V.P. of Finance & CFO

Susan Horvath Latest Holdings Summary

Susan Horvath currently owns a total of 1 stock. Susan Horvath owns 894 shares of Panbela Therapeutics Inc (PBLA) as of January 30, 2023, with a value of $358.

Latest Holdings of Susan Horvath

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
PBLA Panbela Therapeutics Inc 2023-01-30 894 0.40 358

Holding Weightings of Susan Horvath


Susan Horvath Form 4 Trading Tracker

According to the SEC Form 4 filings, Susan Horvath has made a total of 1 transactions in Panbela Therapeutics Inc (PBLA) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Panbela Therapeutics Inc is the acquisition of 222 shares on January 30, 2023, which cost Susan Horvath around $6,799.

Insider Trading History of Susan Horvath

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Susan Horvath Trading Performance

GuruFocus tracks the stock performance after each of Susan Horvath's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Susan Horvath is -64.12%. GuruFocus also compares Susan Horvath's trading performance to market benchmark return within the same time period. The performance of stocks bought by Susan Horvath within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Susan Horvath's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Susan Horvath

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -36.73 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) -35.82 LIMIT LIMIT LIMIT LIMIT LIMIT

Susan Horvath Ownership Network

Ownership Network List of Susan Horvath

No Data

Ownership Network Relation of Susan Horvath

Insider Network Chart

Susan Horvath Owned Company Details

What does Panbela Therapeutics Inc do?

Who are the key executives at Panbela Therapeutics Inc?

Susan Horvath is the V.P. of Finance & CFO of Panbela Therapeutics Inc. Other key executives at Panbela Therapeutics Inc include director & President and CEO Jennifer K. Simpson , 10 percent owner Ryan Randall Gilbertson , and 10 percent owner Ryan R. Gilbertson 2012 Irrevocable Trust .

Panbela Therapeutics Inc (PBLA) Insider Trades Summary

Over the past 18 months, Susan Horvath made 1 insider transaction in Panbela Therapeutics Inc (PBLA) with a net purchase of 4,444. Other recent insider transactions involving Panbela Therapeutics Inc (PBLA) include a net sale of 72,874 shares made by Goldman Sachs Group Inc , a net purchase of 4,444 shares made by Jennifer K. Simpson ,

In summary, during the past 3 months, insiders sold 0 shares of Panbela Therapeutics Inc (PBLA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 3,644 shares of Panbela Therapeutics Inc (PBLA) were sold and 444 shares were bought by its insiders, resulting in a net sale of 3,199 shares.

Panbela Therapeutics Inc (PBLA)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Panbela Therapeutics Inc Insider Transactions

No Available Data

Susan Horvath Mailing Address

Above is the net worth, insider trading, and ownership report for Susan Horvath. You might contact Susan Horvath via mailing address: 4645 Ithaca Lane, Plymouth Mn 55446.

Discussions on Susan Horvath

No discussions yet.